techulon.com techulon.com

techulon.com

Techulon - Home Page

Techulons New MRSA Drug Demonstrates Superior Results. Our research is providing new treatments for intractable diseases. Techulon is Helping Reduce the Risk of Deadly Infections to our US Forces. World Health Organization Declares Antibiotic Resistance a Serious Worldwide Health Threat. Targeted Solutions for Targeted Diseases. Our scalable platform improves discovery outcomes and lowers healthcare expenses. Our targeted therapeutics opens new treatment options for physicians to improve patient care.

http://www.techulon.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR TECHULON.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 11 reviews
5 star
8
4 star
0
3 star
1
2 star
0
1 star
2

Hey there! Start your review of techulon.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.6 seconds

CONTACTS AT TECHULON.COM

1&1 Internet, Inc. - http://1and1.com/contact

Oneandone Private Registration

701 Lee ●●●●●●●●uite 300

Ches●●●●rook , PA, 19087

US

1.87●●●●4254
pr●●●●●●●●●●@1and1-private-registration.com

View this contact

1&1 Internet, Inc. - http://1and1.com/contact

Oneandone Private Registration

701 Lee ●●●●●●●●uite 300

Ches●●●●rook , PA, 19087

US

1.87●●●●4254
pr●●●●●●●●●●@1and1-private-registration.com

View this contact

1&1 Internet, Inc. - http://1and1.com/contact

Oneandone Private Registration

701 Lee ●●●●●●●●uite 300

Ches●●●●rook , PA, 19087

US

1.87●●●●4254
pr●●●●●●●●●●@1and1-private-registration.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2008 April 07
UPDATED
2014 April 08
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 17

    YEARS

  • 0

    MONTHS

  • 22

    DAYS

NAME SERVERS

1
ns57.1and1.com
2
ns58.1and1.com

REGISTRAR

1 & 1 INTERNET AG

1 & 1 INTERNET AG

WHOIS : whois.schlund.info

REFERRED : http://1and1.com

CONTENT

SCORE

6.2

PAGE TITLE
Techulon - Home Page | techulon.com Reviews
<META>
DESCRIPTION
Techulons New MRSA Drug Demonstrates Superior Results. Our research is providing new treatments for intractable diseases. Techulon is Helping Reduce the Risk of Deadly Infections to our US Forces. World Health Organization Declares Antibiotic Resistance a Serious Worldwide Health Threat. Targeted Solutions for Targeted Diseases. Our scalable platform improves discovery outcomes and lowers healthcare expenses. Our targeted therapeutics opens new treatment options for physicians to improve patient care.
<META>
KEYWORDS
1 leadership
2 news
3 research
4 platform
5 approach
6 applications
7 pipeline
8 partnering
9 learn more
10 our platform
CONTENT
Page content here
KEYWORDS ON
PAGE
leadership,news,research,platform,approach,applications,pipeline,partnering,learn more,our platform,our approach,our programs
SERVER
Microsoft-IIS/6.0
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Techulon - Home Page | techulon.com Reviews

https://techulon.com

Techulons New MRSA Drug Demonstrates Superior Results. Our research is providing new treatments for intractable diseases. Techulon is Helping Reduce the Risk of Deadly Infections to our US Forces. World Health Organization Declares Antibiotic Resistance a Serious Worldwide Health Threat. Targeted Solutions for Targeted Diseases. Our scalable platform improves discovery outcomes and lowers healthcare expenses. Our targeted therapeutics opens new treatment options for physicians to improve patient care.

INTERNAL PAGES

techulon.com techulon.com
1

Techulon - Leadership

http://www.techulon.com/Company/Leadership

Mr Harris is an original founding investor in Techulon and has extensive technology commercialization experience in both defense sectors as well as pharmaceutical development. Mr. Harris has led the funding activity for numerous biotech startups, including Protea, a publically traded biotherapeutics company. Mr. Harris has experience in securing federal funding and assists in the development of the company’s grant strategy as well as working with DoD agencies such as DARPA. Mel Affrime, Clinical Planning.

2

Techulon - Pipeline

http://www.techulon.com/Pipeline

Techulon is advancing several therapeutics toward clinical trials through an aggressive translational program. Our lead candidate is targeted at MRSA and we expect to introduce into Phase I trials by 2016. Other candidates have been identified and are currently being optimized through pre-clinical research. In particular, our pipeline is strong in Gram-negative bacteria targets. Gram Negative (RANT 3). Web Solution by IDD, Inc.

3

Techulon - Partnering

http://www.techulon.com/Partnering

Our specific delivery platform coupled with our library of validated targets make Techulon an ideal partner to provide superior therapeutic performance in a wide range of indications. Our current work in drug resistant bacteria provides a wide range of opportunities in orphan indications as well. We are actively seeking potential collaboration or licensing opportunities to explore the therapeutic potential of our platform in diseases in the United States and globally. Please ignore this field.

4

Techulon - Applications

http://www.techulon.com/Applications

Drug Resistant Bacteria — A Mounting Concern. Drug resistant bacteria pose a serious threat to clinical settings including hospitals, clinical outpatient care facilities, and military operating areas subjected to the needs of burn victims and wound care. The World Health Organization recently released a report on the global public health threat of antibiotic resistant infections. DARPA has provided Techulon with $1.9M to develop drugs for wounded soldiers who are susceptible to infections. Techulon&rsquo...

5

Techulon - Company

http://www.techulon.com/Company/About

Techulon evolved from core research initiated at the College of Science at Virginia Tech in Blacksburg, VA. The company expanded its focus through the research efforts required to translate simple nucleic acid delivery systems. In 2010, the company established partnerships to expand its capability in delivery. 2010 First commercial platform license. 2010 Partnership with Novartis. 2011 Winner Phase I SBIR DARPA. 2012 First trials in animals. 2013 Phase II SBIR DARPA. 2014 Optimized efficacy in MRSA model.

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL PAGES IN THIS WEBSITE

6

LINKS TO THIS WEBSITE

yesmontgomeryva.org yesmontgomeryva.org

Montgomery County Economic Development - Biosciences & Healthcare Cluster

http://yesmontgomeryva.org/biosciences-and-healthcare

Montgomery County Economic Development. Facts, Maps and Stats. The Montgomery County biosciences industry is clustered in the Virginia Tech Corporate Research Center. CRC) - a 220 acre research park in Blacksburg. The CRC is home to over 21 bioscience companies and research centers. Biosciences is also a major research focus area for Virginia Tech. Montgomery County is also home to two hospitals, LewisGale at Montgomery (Blacksburg) and Carilion New River Valley Medical Center (Christiansburg). Blacksbur...

UPGRADE TO PREMIUM TO VIEW 7 MORE

TOTAL LINKS TO THIS WEBSITE

8

OTHER SITES

techulearn.org techulearn.org

TechULearn - Home

Workshops, Parties and More. TechULearn provides trainings, consultations, and staff development of digital applications and hardware to community, businesses, and educational institutions. Sign up below to be notified of upcoming trainings! Our mission is to provide our clients with the knowledge and skills needed to succeed in the ever-changing world of technology. 2015 TechULearn, LLC. / Images courtesy of.

techuliar.wordpress.com techuliar.wordpress.com

Techuliar | Software testing, industry analysis and more.

Software testing, industry analysis and more. Installing Octave on MacOSX. September 10, 2012. Fink install instructions are here: http:/ www.finkproject.org/download/srcdist.php. The command “fink selfupdate-rsync” takes forever, be patient. Once installed, I did:. Sudo xcodebuild -license # you need to accept the license agreement or the fink install of octave errors out. Sudo fink -b install octave. HTH someone on the web, I spent the better part of a day doing this. OSX: Learning the ropes. Its also ...

techulike.com techulike.com

techulike

End Point Security Solutions. Product Life Cycle Management. In-built Anti-Virus, Intrusion Prevention System, 3G Ready. View details ». View details ». CCTV - Cat TV. View details ».

techullclean.com techullclean.com

TecHullClean Limited | Environmentally friendly hull cleaning equipment and solutions.

About TecHullClean Return to Top. TecHullClean Limited is a newly established underwater hull cleaning company specializing in the development and manufacture of environmentally friendly hull cleaning equipment and solutions, in line with IMO MEPC.207(62). All equipment is designed, tested and approved in collaboration with the University of Cadiz, major shipping lines and global anti-fouling paint manufacturers. The Team Return to Top. Service Locations Return to Top. Contact Us Return to Top.

techuloid.com techuloid.com

TECHULOID - Welcome to the world of Technology

August 14, 2015. 45th Kerala State Film Awards 2014 – Full winners list. August 10, 2015. Kerala State Film Awards is presented by Kerala State Chalachitra Academy which recognizes the talents from Malayalam film industry. 45th Kerala State Film Awards 2014 is announced on 10th August 2015 by Thiruvanchoor Radhakrishnan, State Minister for Forest Transport, Sports, Environment, and Cinema. We have the full winners list of Kerala State Awards 2014 here. […]. Nehru Trophy Boat Race (Vallamkali) 2015 Results.

techulon.com techulon.com

Techulon - Home Page

Techulons New MRSA Drug Demonstrates Superior Results. Our research is providing new treatments for intractable diseases. Techulon is Helping Reduce the Risk of Deadly Infections to our US Forces. World Health Organization Declares Antibiotic Resistance a Serious Worldwide Health Threat. Targeted Solutions for Targeted Diseases. Our scalable platform improves discovery outcomes and lowers healthcare expenses. Our targeted therapeutics opens new treatment options for physicians to improve patient care.

techulosity.com techulosity.com

TECHULOSITY

Friday, March 1, 2013. Latest Instagram Obsession: Photographer Murad Osmann Follows Girlfriend - Literally Everywhere. I am beyond. I mean, BEYOND. When my old editor Neil Katz brought this Instagram-to-follow. To my attention, I swooned. Don't let the headline of this post fool you. There's lots to love about following your girlfriend - everywhere. No, it's not creepy at all. Or at least, not for Murad Osmann who's clearly enamored of his girlfriend. And rightfully so - she's hot.). Links to this post.

techulous.com techulous.com

techulous.com

Inquire about this domain.

techulsanchez.wordpress.com techulsanchez.wordpress.com

techulsanchez | This WordPress.com site is the cat’s pajamas

It seems we can’t find what you’re looking for. Perhaps searching can help. This WordPress.com site is the cat’s pajamas. Create a free website or blog at WordPress.com. Create a free website or blog at WordPress.com.

techultima.blogspot.com techultima.blogspot.com

Tech Ultima

Technology news feeds . Computer and mobile games and inventions . Tuesday, January 22, 2013. Galaxy S4 Release Date Is Not MWC 2013. Galaxy S4 - جلاكسي اس 4. Links to this post. Monday, September 10, 2012. Iphone 5 in all over the world in one appointment. Iphone 5 in all over the world in one appointment. Britain's first 4G mobile network hopes for. LEAKED Official Apple iPhone 5 Promo Video - Keynote 2012. Links to this post. Sunday, September 9, 2012. IPhone 5, is that you? The new iphone 5. 1Choose ...

techultima.com techultima.com

Netfirms | This site is temporarily unavailable

Netfirms offers a full money-back guarantee. 24/7 Sales Toll-Free: 866-317-4678. Powering over 1,200,000. Return to Home Page. This site is temporarily unavailable. If you manage this site and have a question about why the site is not available, please contact NetFirms directly.